| 영문 | neonatal intensive care center | 한글 | 신생아 집중치료실 |
|---|---|---|---|
| 설명 | 미숙아나 가사 상태의 출산아를 집중적으로 보살피고 치료하는 기관. |
||
| 영문 | icterus, jaundice | 한글 | 황달 |
|---|---|---|---|
| 설명 | 혈액 중에 빌리루빈 양이 증가하여 피부 및 점막내 담즙의 축적으로 황색을 나타내는 병적상태. 빌리루빈은 적혈구에 함유되는 혈색소의 체내에서의 대사산물이며, 간 또는 그 밖의 특수한 세포 속에서 만들어지고 쓸개즙 속에 함유되어 배설되는 적황색 색소이다. 원인은 다음과 같이 셋으로 크게 나눈다. ① 폐색성 황달: 쓸개돌이나 종양 등에 의하여 담관에서 장관으로 유출되어야 할 담즙이 쓸개관의 폐색에 의하여 유출장애를 일으킨 경우. ② 간세포성 황달 및 간세쓸개관성 황달: 간세포의 기능장애에 의한 담즙분비장애를 일으키는 경우로 급성간염에 의하여 대표되는 것. ③ 용혈황달: 과잉의 혈구 파괴로 인하여 일어나는 것으로 주로 용혈성 빈혈인 경우에 일어나는 것이 있다. 또 증세를 경중에 따라 구별하면, 카타르성 황달은 경도의 증세인 경우이며, 두통-권태감 외에 맥박이 느려지고, 때로는 피부가 가려워진다. 중증 황달은 위독한 증세이며, 발열-간부분의 통증, 혼수 등을 볼 수 있고, 급성 간위축증-간경화증-간암 등의 경우에 볼 수 있다. |
||
| CBD | Common Bile Duct - Absolute Ix of CBD Exploration 1. Palp... |
|---|---|
| EOJ | extrahepatic obstructive jaundice |
| jaund | jaundice |
| d/t | due to |
| dt | due to; dystonic |
| OJ | Obstructive jaundice |
|---|---|
| DUE | DNA unwinding element |
| DUE | Drug usage evaluation |
| PVSG | Polycythaemia Vera Study Group |
| PRV | Polycythaemia rubra vera |
| neonatal jaundice | Icterus which can be accentuated by many factors including excessive haemolysis, sepsis, neonatal hepatitis or congenital atresia of the biliary system. Synonym: physiologic icterus, jaundice of the newborn, neonatal jaundice, physiologic jaundice. (05 Mar 2000) |
|---|---|
| jaundice, neonatal | The jaundice sometimes seen in newborn infants. It is also called icterus neonatorum. (12 Dec 1998) |
| polycythaemia | <haematology> Increase in the haemoglobin content of the blood, either because of a reduction in plasma volume or an increase in red cell numbers. The latter may be a result of abnormal proliferation of red cell precursors (polycythaemia vera, Vaquez Osler disease). Origin: Gr. Haima = blood (18 Nov 1997) |
| polycythaemia rubra vera | <haematology> A condition characterised by enlargement of the spleen and the increased production of red blood cells by the bone marrow. Diagnosis is based on an increased number and volume of red cells. The total number of white blood cells and platelets may also be increased. Treatment will vary according to the age of the patient and severity of the disease. This condition carries an increased risk of developing acute leukaemia. The disease usually begins in late middle life and is slightly more common in males. (11 Nov 1997) |
| polycythaemia vera | <haematology> A condition characterised by enlargement of the spleen and the increased production of red blood cells by the bone marrow. Diagnosis is based on an increased number and volume of red cells. The total number of white blood cells and platelets may also be increased. Treatment will vary according to the age of the patient and severity of the disease. This condition carries an increased risk of developing acute leukaemia. The disease usually begins in late middle life and is slightly more common in males. (11 Nov 1997) |
| due date | The estimated calendar date when a baby will be born, the date the baby is due to be born. It is also called the estimated date of confinement (EDC). (12 Dec 1998) |
| dystonia, focal, due to blepharospasm | The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal. (12 Dec 1998) |
| dystonia, focal, due to torticollis | Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward. (12 Dec 1998) |
| thrombotic disease due to protein c deficiency | Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal. (12 Dec 1998) |
| anaemia, neonatal | The mildest form of erythroblastosis foetalis in which anaemia is the chief manifestation. (12 Dec 1998) |
| benign neonatal convulsions | A familial, self-limited epilepsy, beginning at two or three days of age and resolving spontaneously by six months of age; autosomal dominant inheritance. (05 Mar 2000) |
| Brazelton's Neonatal Behavioural Assessment Scale | A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life. (05 Mar 2000) |
| rate, neonatal mortality | The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990. (12 Dec 1998) |
| mortality rate, neonatal | The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990. (12 Dec 1998) |
| neonatal | <paediatrics> Pertaining to the first four weeks after birth. Origin: L. Natus = born (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|